Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why PAVmed Soared by 12% on Wednesday

TheMotleyFool

0 0

Why PAVmed Soared by 12% on WednesdayPhoto, wide shot, wide-angle lens, Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png

PAVmed (NASDAQ: PAVM) was a winner on Wednesday. The medical device maker's stock rose by over 12% on the back of a key appointment to the board of directors of its most important subsidiary.

That appointment is of Stanley Lapidus, the founder and onetime CEO of DNA-based diagnostics company Exact Sciences (NASDAQ: EXAS). Lapidus has been tapped to be vice chairman of the board of Lucid Diagnostics, the home of PAVmed's core suite of cancer testing products.

Image source: Getty Images.

Source Fool.com

Like: 0

EXAS

Teilen